Indistinguishable mitochondrial phenotypes after exposure of healthy myoblasts to myalgic encephalomyelitis or control serum
Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome is a disease of uncertain aetiology that affects up to 400,000 individuals in the UK. Exposure of cultured cells to the sera of people with ME has been proposed to cause phenotypic changes in these cells in vitro when compared to sera from healthy controls. ME serum factors causing these changes could inform the development of diagnostic tests. In this study, we performed a large-scale, pre-registered replication of an experiment from Fluge et al (2016) that reported an increase in maximal respiratory capacity in healthy myoblasts after treatment with serum from people with ME compared to serum from healthy controls. We replicated the original experiment with a larger sample size, using sera from 67 people with ME and 53 controls to treat healthy cultured myoblasts, and generated results from over 1,700 mitochondrial stress tests performed with a Seahorse Bioanalyser. We observed no significant differences between treatment with ME or healthy control sera for our primary outcome of interest, oxygen consumption rate at maximal respiratory capacity. Results from our study provide strong evidence against the hypothesis that ME blood factors differentially affect healthy myoblast mitochondrial phenotypes in vitro. ### Competing Interest Statement The authors have declared no competing interest. Action for ME, https://ror.org/0569v7v35, Clare Francis Research Fellowship
1/2 New pre-print: We performed a large-scale replication testing the effect of serum from 67 pwME and 53 healthy donors on muscle cell mitochondria, revealing no significant differences. This suggests earlier results may not be true for people with ME in general. doi.org/10.1101/2025...
09.06.2025 12:13 — 👍 17 🔁 5 💬 2 📌 0
Frontiers | Deep sequencing of BCR heavy chain repertoires in myalgic encephalomyelitis/chronic fatigue syndrome
Pleased to share this research from my PhD in @graemecowan.bsky.social's lab! We replicated existing evidence of moderately increased IGHV3-30 usage in B cells of patients with mild/moderate, but not severe ME. www.frontiersin.org/journals/imm...
17.02.2025 11:01 — 👍 24 🔁 11 💬 2 📌 2
Interested in Audrey's research? 🤔
"I’m trying to understand whether there are factors in the blood of ME patients that are different from healthy individuals."
We're raising funds to support & fund fellowships, like Audrey's
Donate today & see your gift doubled 👇
tinyurl.com/afme-bgcc24
#pwME
06.12.2024 12:04 — 👍 9 🔁 5 💬 0 📌 0
Help for today, hope for tomorrow
ME is a long term, neurological disease affecting hundreds of thousands - yet there is still no test, no effective …
@actionforme.bsky.social are running their Big Give campaign this week to raise money for ME and ME research, with matched donations up to Monday! AfME have been supporting Audrey Ryback's important research on blood factors in ME. Do consider donating and sharing! donate.biggive.org/campaign/a05...
06.12.2024 12:40 — 👍 1 🔁 0 💬 0 📌 0
Providing support & holistic healthcare services to people of all ages affected by #MECFS
Charity number: 1036419 / SC040452
Associate Prof. @univie Mainly tweeting on animal development & evolution. also @ tim_wollesen@mastodon.world. Personal account - views are not of my working group or employer
Retired maths teacher. ME/CFS 35 years. Volunteer staff member on Science for ME international forum, www.s4me.info
Ehemann, Jurist. #MECFS.
Team #SIGNforMECFS. Team #GOfundMECFS.
One of the #MillionsMissing.
Author of "stranger and stranger”, letter writer, advocate and fundraiser for biomedical ME/CFS research.
Pediatrician &
Professor of Pediatric Immunology
Human Systems Immunology
MRC LMS, Imperial College London
& Karolinska Institutet
Mostly posting about Long Covid
Evolutionary molecular biologist/biochemist | Postdoc @ UQ, Brisbane | former PhD @ EMBL, Heidelberg | Sponges, other non-Bilaterians and proteomics
Bioinformatics Scientist / Next Generation Sequencing, Single Cell and Spatial Biology, Next Generation Proteomics, Liquid Biopsy, SynBio, Compute Acceleration in biotech // http://albertvilella.substack.com
I occasionally try to explain and comment on ME researchh, or even contribute to it. And I advocate for more and better research.
#LongCovid | researcher | Covid | infectious disease | health, disability, inequality in present and past | human-environment interactions | big data | medicine history | patient-led research | MA PHD| ≠ MD |
Researching the cell biology of ME/CFS since 2016, now also Long COVID and PD. Papers: https://scholars.latrobe.edu.au/d2missailidi/publications
Wir unterstützen Menschen mit ME/CFS (Myalgische Enzephalomyelitis / Chronisches Fatigue Syndrom) und setzen uns seit 1993 für Versorgung, Forschung und Aufklärung ein.
Größte deutsche Patientenorganisation mit gut 3.000 Mitgliedern.
physician-researcher, paediatrician, ME/CFS since 2016. This account is about science, esp. CFS
Immunologist and ME/CFS researcher @Charité
https://cfc.charite.de/
Facharzt für Neurologie
ME/CFS ▪ Long Covid ▪ Nervenultraschall ▪ ENG/EMG ▪ Hirngesundheit ▪ Telemedizin
Research Scientist who prefers facts to lies. Focus on Long COVID. Free book: http://osf.io/pnxcs/.
An independent group of scientists providing transparent advice during the COVID crisis.
RTHM is a secure health platform that makes it easy to gather your records, connect the dots with AI, and affordably access treatments.